References
- Haria M, Fitton A, McTavish D. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging. 1994;4(4):331–355.
- Kane SP. Trazodone, ClinCalc DrugStats Database, Version 2021.10; [updated 2021 Sept 15; cited 2021 Dec 13]. Available from: https://clincalc.com/DrugStats/Drugs/Trazodone
- Trazodone [package insert]. Locust Valley, NY: Pragma Pharmaceuticals, LLC; 2017.
- Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14(7-8):24–34.
- Service JA, Waring WS. QT prolongation and delayed atrioventricular conduction caused by acute ingestion of trazodone. Clin Toxicol. 2008;46(1):71–73.
- Camacho LD, Stearns J, Amini R. Management of trazodone overdose with severe hypotension. Case Rep Emerg Med. 2019;2019:2470592.
- Soe KK, Lee MY. Arrhythmias in severe trazodone overdose. Am J Case Rep. 2019;20:1949–1955.
- Winkler D, Ortner R, Pjrek E, et al. Trazodone-induced cardiac arrhythmias: a report of two cases. Hum Psychopharmacol. 2006;21(1):61–62.
- de Meester A, Carbutti G, Gabriel L, et al. Fatal overdose with trazodone: case report and literature review. Acta Clin Belg. 2001;56(4):258–261.
- White N, Litovitz T, Clancy C. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. J Med Toxicol. 2008;4(4):238–250.
- El Zahran T, Morgan BW, Hon S, et al. Unintentional trazodone overdoses in children ≤6 years of age: data from poison center over a period of 16 years. Clin Toxicol. 2019;57(1):56–59.
- Nelson JC, Spyker DA. Morbidity and mortality associated with medications used in the treatment of depression: an analysis of cases reported to U.S. Poison control centers, 2000-2014. Am J Psychiatry. 2017;174(5):438–450.
- Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual report of the american association of poison control centers’ national poison data system (NPDS): 37th annual report. Clin Toxicol. 2020;58(12):1360–1541.
- Anderson BD, Seung H, Klein-Schwartz W. Trends in types of calls managed by U.S. poison centers 2000-2015. Clin Toxicol. 2018;56(7):640–645.
- Bertisch SM, Herzig SJ, Winkelman JW, et al. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014;37(2):343–349.
- Wong J, Horwitz MM, Bertisch SM, et al. Trends in dispensing of zolpidem and Low-Dose trazodone among commercially insured adults in the United States, 2011-2018. JAMA. 2020;324(21):2211–2213.
- Forrester MB. Immediate- and controlled-release zolpidem ingestions reported to Texas poison centers. Hum Exp Toxicol. 2009;28(8):505–509.
- Lee S, Lee HA, Kim SJ, et al. Cellular mechanisms for trazodone-induced cardiotoxicity. Hum Exp Toxicol. 2016;35(5):501–510.
- Campleman SL, Brent J, Pizon AF, et al. Toxicology investigators’ consortium (ToxIC). drug-specific risk of severe QT prolongation following acute drug overdose. Clin Toxicol. 2020;58(12):1326–1334.